<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-JGYR735V</identifier><date>2014</date><creator>Balogova, S.</creator><creator>Fettich, Jurij</creator><creator>Hodolič, Marina</creator><creator>Huchet, V.</creator><creator>Kerrou, K.</creator><creator>Michaud, Laure</creator><creator>Nataf, V.</creator><creator>Talbot, Jean-Noël</creator><creator>Vereb, M.</creator><relation>documents/doc/J/URN_NBN_SI_doc-JGYR735V_001.pdf</relation><relation>documents/doc/J/URN_NBN_SI_doc-JGYR735V_001.txt</relation><format format_type="issue">1</format><format format_type="volume">48</format><format format_type="type">article</format><format format_type="extent">str. 20-28</format><identifier identifier_type="COBISSID">1067180</identifier><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-JGYR735V</identifier><language>eng</language><language>slv</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">bone scintigraphy</subject><subject language_type_id="slv">fluoride(18F)</subject><subject language_type_id="slv">fluorocholine (FCH)</subject><subject language_type_id="eng">indication of imaging</subject><subject language_type_id="slv">PET/CT</subject><subject language_type_id="slv">prostata</subject><subject language_type_id="eng">prostate</subject><subject language_type_id="slv">prostate cancer</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">slikovna diagnostika</subject><title>a dual centre survey</title><title>Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer</title></Record>